Newborn Screening for Severe Combined Immunodeficiency.
Newborn screening (NBS)
Severe combined immunodeficiency (SCID)
T-cell lymphopenia
T-cell receptor excision circle (tREC)
Journal
Immunology and allergy clinics of North America
ISSN: 1557-8607
Titre abrégé: Immunol Allergy Clin North Am
Pays: United States
ID NLM: 8805635
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
entrez:
4
10
2021
pubmed:
5
10
2021
medline:
4
11
2021
Statut:
ppublish
Résumé
The T-cell receptor excision circle (TREC) assay is an effective screening tool for severe combined immunodeficiency (SCID). The TREC assay was designed to detect typical SCID and leaky SCID, but any condition causing low naïve T-cell counts will also be detected. Newborn screening for SCID using the TREC assay has proven itself to be highly sensitive and cost-efficient. This review covers the history of SCID newborn screening, elaborates on the SCID subtypes and TREC assay limitations, and discusses diagnostic and management considerations for infants with a positive screen.
Identifiants
pubmed: 34602227
pii: S0889-8561(21)00058-8
doi: 10.1016/j.iac.2021.07.007
pii:
doi:
Substances chimiques
Receptors, Antigen, T-Cell
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
543-553Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.